CAMBRIDGE, England & BOSTON--(BUSINESS WIRE)-- Bicycle Therapeutics plc (NASDAQ:BCYC), a biotechnology company pioneering a new and differentiated class of therapeutics based on its proprietary ...
(RTTNews) - Bicycle Therapeutics plc (BCYC) announced Wednesday that the U. S. Food and Drug Administration has granted Fast Track Designation or FTD to its BT8009 monotherapy to treat adult patients ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback